Abstract P3-11-05: Predictive gene signatures of adjuvant capecitabine benefit in triple negative breast cancer in the FinXX trialSaranya Chumsri, E. Aubrey Thompson, HA Brauer et al.|Cancer Research|2019Cited by 1